Anti-CD99 monoclonal antibodies were able to induce caspase-independent cell death of AML cell lines and primary blasts [305], T-cell lines [306] and BCP-ALL cells bearing the TEL/AML1 fusion [307]. The gene discussed is RUNX1; the disease is acute lymphoblastic leukemia.